https://pubmed.ncbi.nlm.nih.gov/25398579/
Interstitial lung disease induced by alectinib (CH5424802/RO5424802)
A 75-year-old woman with anaplastic lymphoma kinase (ALK)-rearranged Stage IV lung adenocarcinoma was administered the selective anaplastic lymphoma kinase...
interstitial lung diseaseinducedalectinib